title: Duration of viral shedding in hospitalized patients infected with pandemic H1N1.
abstract: BACKGROUND
  The first influenza pandemic of the 21th century was ignited by a new strain of influenza A virus (A/H1N1pdm). Specific patient groups, including those with comorbidities, pregnant women, young children, older and immunocompromised patients, are at increased risk for serious influenza-related disease. This study was aimed at investigating the influence of clinical presentation, antiviral treatment and possible drug resistance-associated mutations, on the extent and duration of viral shedding in patients infected with A/H1N1pdm.
  
  
  METHODS
  An observational study was performed, based on retrospective review of clinical and laboratory records of patients who were hospitalized for A/H1N1pdm infection at the National Institute for Infectious Diseases "L. Spallanzani", Rome, Italy, between April 24 and December 31, 2009. Among 119 hospitalized patients, 39 were selected for a post hoc analysis, based on the availability of serial nasopharyngeal swabs samples and related information.
  
  
  RESULTS
  Eleven out of the 39 study patients (28.2%) presented with pneumonia; 29 (74.4%) received antiviral treatment. Patients with pneumonia were significantly older than patients without pneumonia. The mean values of viral RNA concentration were not significantly increased in patients with pneumonia, but a significant increase in the duration of viral shedding was observed as compared to patients without pneumonia. In patients receiving antivirals, the viral RNA concentration was significantly reduced in comparison to untreated patients at days 4-5 after symptom onset, while the overall duration of viral shedding was only marginally affected. A significant correlation between duration of viral shedding and time elapsed between symptom onset and therapy start was observed, with a significant reduction of days of viral shedding when therapy was initiated within 2 days of symptoms appearance. No known drug resistance mutations were detected in patients with prolonged viral shedding.
  
  
  CONCLUSIONS
  Our results show that severe respiratory illness is associated with delayed virus clearance in patients with A/H1N1pdm infection. Antivirals caused an early reduction of viral load, but only marginally affected the overall duration of shedding. Prolonged shedding was not associated with the emergence of strains carrying known drug-resistance mutations.
authors: Laboratory of Virology, National Institute for Infectious Diseases L, Spallanzani, 292 Via Portuense, Rome, Italy.
authors: Silvia
authors: S
authors: Meschi
authors: Marina
authors: M
authors: Selleri
authors: Eleonora
authors: E
authors: Lalle
authors: Licia
authors: L
authors: Bordi
authors: Maria B
authors: MB
authors: Valli
authors: Federica
authors: F
authors: Ferraro
authors: Giuseppe
authors: G
authors: Ippolito
authors: Nicola
authors: N
authors: Petrosillo
authors: Francesco N
authors: FN
authors: Lauria
authors: Maria R
authors: MR
authors: Capobianchi
references: Ann Intern Med. 2010 Nov 16;153(10):655-7
references: 21079221
references: J Infect Dis. 2010 Sep 1;202(5):681-9
references: 20670171
references: Emerg Infect Dis. 2010 Aug;16(8):1265-72
references: 20678321
references: MMWR Morb Mortal Wkly Rep. 2009 May 1;58(16):433-5
references: 19407738
references: Am J Prev Med. 2010 Feb;38(2):121-6
references: 19850440
references: MMWR Morb Mortal Wkly Rep. 2010 Jan 8;58(51):1436-40
references: 20057350
references: Antivir Ther. 2007;12(4):501-8
references: 17668558
references: J Infect Dis. 2010 Jun 1;201(11):1654-62
references: 20423224
references: BMC Infect Dis. 2010 Jun 10;10:164
references: 20537158
references: J Infect Dis. 2009 Aug 15;200(4):492-500
references: 19591575
references: N Engl J Med. 2010 Jan 7;362(1):86-7
references: 20007549
references: J Clin Virol. 2010 Jul;48(3):220-2
references: 20447860
references: J Med Virol. 2010 Jan;82(1):1-7
references: 19950247
references: Euro Surveill. 2009 Dec 10;14(49):
references: 20003906
references: N Engl J Med. 2010 Jan 7;362(1):27-35
references: 20032319
references: N Engl J Med. 2009 Dec 3;361(23):2204-7
references: 19884645
references: N Engl J Med. 2009 Nov 12;361(20):1935-44
references: 19815859
references: Clin Infect Dis. 2010 Mar 15;50(6):850-9
references: 20136415
references: N Engl J Med. 2009 Dec 24;361(26):2507-17
references: 20007555
references: PLoS Med. 2010 May 18;7(5):e1000277
references: 20502525
references: Clin Infect Dis. 2010 May 1;50(9):1252-5
references: 20345239
references: JAMA. 1999 Oct 6;282(13):1240-6
references: 10517426
references: N Engl J Med. 2010 May 6;362(18):1708-19
references: 20445182